Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

CDK inhibitor induces apoptosis and tumor necrosis in a dog with malignant melanoma

Jan. 12, 1998

FDA approves Photofrin for early-stage lung cancer

Jan. 12, 1998

New mycotoxin with antitumor and favorable hematological effects

Jan. 12, 1998

Good in vitro activity reported for Novartis PKC inhibitor

Jan. 12, 1998

Merck continues to devote extensive R&D efforts to FTase inhibitors

Jan. 12, 1998

New phosphatase inhibitors from the University of Pittsburgh

Jan. 9, 1998

New rationale elucidated for clinical evaluation of GW-506U in refractory hematologic malignancies

Jan. 9, 1998

New vitamin D conjugates disclosed by Clarion

Jan. 8, 1998

Protein farnesyltransferase inhibitors disclosed by Schering-Plough

Jan. 8, 1998

Photofrin approval sought in nine additional European countries

Jan. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...